It didn’t take long for the coming AGM season to once again demonstrate that shareholder democracy is more honoured in the breach than the observance.
At Australian Clinical Labs, chaired by Crescent Capital founder Michael Alscher, a contentious resolution to award CEO Melinda McGrath options worth $900,000 was withdrawn 11 days before being formally put to shareholders.
Loading...
Myriam Robin is Rear Window editor based in the Melbourne newsroom. A Rear Window columnist since 2017, she previously reported on financial markets and media. Connect with Myriam on Twitter. Email Myriam at myriam.robin@afr.com
